Literature DB >> 33416917

High-dose midodrine is not effective for treatment of persistent hypotension in the intensive care unit.

Peter Santer1, Matthias Eikermann2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33416917     DOI： 10.1007/s00134-020-06333-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Midodrine administration during critical illness: fixed-dose or titrate to response?

Authors:  Richard R Riker; David J Gagnon
Journal:  Intensive Care Med       Date:  2020-11-25       Impact factor: 17.440

Review 2.  Epidural Local Anesthetics Versus Opioid-Based Analgesic Regimens for Postoperative Gastrointestinal Paralysis, Vomiting, and Pain After Abdominal Surgery: A Cochrane Review.

Authors:  Joanne Guay; Mina Nishimori; Sandra L Kopp
Journal:  Anesth Analg       Date:  2016-12       Impact factor: 5.108

3.  Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions.

Authors:  Alexander R Levine; Matthew J Meyer; Edward A Bittner; Sheri Berg; Rebecca Kalman; Anne B Stanislaus; Cheryl Ryan; Stephanie A Ball; Matthias Eikermann
Journal:  J Crit Care       Date:  2013-07-08       Impact factor: 3.425

4.  A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension.

Authors:  R A Wright; H C Kaufmann; R Perera; T L Opfer-Gehrking; M A McElligott; K N Sheng; P A Low
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

5.  Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems.

Authors:  Annika Reintam Blaser; Manu L N G Malbrain; Joel Starkopf; Sonja Fruhwald; Stephan M Jakob; Jan De Waele; Jan-Peter Braun; Martijn Poeze; Claudia Spies
Journal:  Intensive Care Med       Date:  2012-02-07       Impact factor: 17.440

6.  Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.

Authors:  Peter Santer; Matthew H Anstey; Maria D Patrocínio; Bradley Wibrow; Bijan Teja; Denys Shay; Shahzad Shaefi; Charles S Parsons; Timothy T Houle; Matthias Eikermann
Journal:  Intensive Care Med       Date:  2020-09-03       Impact factor: 17.440
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.